Matching Items (2)
151433-Thumbnail Image.png
Description
Sensitivity is a fundamental challenge for in vivo molecular magnetic resonance imaging (MRI). Here, I improve the sensitivity of metal nanoparticle contrast agents by strategically incorporating pure and doped metal oxides in the nanoparticle core, forming a soluble, monodisperse, contrast agent with adjustable T2 or T1 relaxivity (r2 or r1).

Sensitivity is a fundamental challenge for in vivo molecular magnetic resonance imaging (MRI). Here, I improve the sensitivity of metal nanoparticle contrast agents by strategically incorporating pure and doped metal oxides in the nanoparticle core, forming a soluble, monodisperse, contrast agent with adjustable T2 or T1 relaxivity (r2 or r1). I first developed a simplified technique to incorporate iron oxides in apoferritin to form "magnetoferritin" for nM-level detection with T2- and T2* weighting. I then explored whether the crystal could be chemically modified to form a particle with high r1. I first adsorbed Mn2+ ions to metal binding sites in the apoferritin pores. The strategic placement of metal ions near sites of water exchange and within the crystal oxide enhance r1, suggesting a mechanism for increasing relaxivity in porous nanoparticle agents. However, the Mn2+ addition was only possible when the particle was simultaneously filled with an iron oxide, resulting in a particle with a high r1 but also a high r2 and making them undetectable with conventional T1-weighting techniques. To solve this problem and decrease the particle r2 for more sensitive detection, I chemically doped the nanoparticles with tungsten to form a disordered W-Fe oxide composite in the apoferritin core. This configuration formed a particle with a r1 of 4,870mM-1s-1 and r2 of 9,076mM-1s-1. These relaxivities allowed the detection of concentrations ranging from 20nM - 400nM in vivo, both passively injected and targeted to the kidney glomerulus. I further developed an MRI acquisition technique to distinguish particles based on r2/r1, and show that three nanoparticles of similar size can be distinguished in vitro and in vivo with MRI. This work forms the basis for a new, highly flexible inorganic approach to design nanoparticle contrast agents for molecular MRI.
ContributorsClavijo Jordan, Maria Veronica (Author) / Bennett, Kevin M (Thesis advisor) / Kodibagkar, Vikram (Committee member) / Sherry, A Dean (Committee member) / Wang, Xiao (Committee member) / Yarger, Jeffery (Committee member) / Arizona State University (Publisher)
Created2012
156742-Thumbnail Image.png
Description
ABSTRACT

Transition metals have been extensively employed to address various challenges

related to catalytic organic transformations, small molecule activation, and energy storage

over the last few decades. Inspired by recent catalytic advances mediated by redox noninnocent

pyridine diimine (PDI) and α-diimine (DI) ligand supported transition metals,

our group has designed new PDI and DI ligands

ABSTRACT

Transition metals have been extensively employed to address various challenges

related to catalytic organic transformations, small molecule activation, and energy storage

over the last few decades. Inspired by recent catalytic advances mediated by redox noninnocent

pyridine diimine (PDI) and α-diimine (DI) ligand supported transition metals,

our group has designed new PDI and DI ligands by modifying the imine substituents to

feature donor atoms. My doctoral research is focused on the development of PDI and DI

ligand supported low valent first row metal complexes (Mn, Fe, Co) and their application

in bond activation reactions and the hydrofunctionalization of unsaturated bonds.

First two chapters of this dissertation are centered on the synthesis and

application of redox non-innocent ligand supported low valent iron complexes. Notably,

reduction of a DI-based iron dibromide led to the formation of a low valent iron

dinitrogen compound. This compound was found to undergo a sequential C-H and C-P

bond activation processes upon heating to form a dimeric compound. The plausible

mechanism for dimer formation is also described here.

Inspired by the excellent carbonyl hydrosilylation activity of our previously

reported Mn catalyst, (Ph2PPrPDI)Mn, attempts were made to synthesize second generation

Mn catalyst, which is described in the third chapter. Reduction of (PyEtPDI)MnCl2

furnished a deprotonated backbone methyl group containing Mn compound

[(PyEtPDEA)Mn] whereas reduction of (Ph2PEtPDI)MnCl2 produced a dimeric compound,

[(Ph2PEtPDI)Mn]2. Both compounds were characterized by NMR spectroscopy and XRD

analysis. Hydrosilylation of aldehydes and ketones have been studied using

[(PyEtPDEA)Mn] as a pre-catalyst. Similarly, 14 different aldehydes and 6 different

ii

formates were successfully hydrosilylated using [(Ph2PEtPDI)Mn]2 as a pre-catalyst.

Encouraged by the limited number of cobalt catalysts for nitrile hydroboration, we

sought to develop a cobalt catalyst that is active for hydroboration under mild conditions,

which is discussed in the last chapter. Treatment of (PyEtPDI)CoCl2 with excess NaEt3BH

furnished a diamagnetic Co(I) complex [(PyEtPDIH)Co], which exhibits a reduced imine

functionality. Having this compound characterized, a broad substrate scope for both

nitriles and imines have been investigated. The operative mechanism for nitrile

dihydroboration has been investigated based on the outcomes of a series of stoichiometric

reactions using NMR spectroscopy.
ContributorsGhosh, Chandrani (Author) / Trovitch, Ryan J. (Thesis advisor) / Seo, Don (Committee member) / Moore, Ana (Committee member) / Arizona State University (Publisher)
Created2018